Page 42 - Read Online
P. 42

Laustsen-Kiel et al. Plast Aesthet Res 2024;11:17  https://dx.doi.org/10.20517/2347-9264.2024.32  Page 13 of 18

               34.       Zehra S, Doyle F, Barry M, Walsh S, Kell MR. Health-related quality of life following breast reconstruction compared to total
                    mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis. Breast Cancer
                    2020;27:534-66.  DOI  PubMed
               35.       Penha TR, Botter B, Heuts EM, Voogd AC, von Meyenfeldt MF, van der Hulst RR. Quality of life in patients with breast cancer-
                    related lymphedema and reconstructive breast surgery. J Reconstr Microsurg 2016;32:484-90.  DOI  PubMed
               36.       Schubart JR, Emerich M, Farnan M, Stanley Smith J, Kauffman GL, Kass RB. Screening for psychological distress in surgical breast
                    cancer patients. Ann Surg Oncol 2014;21:3348-53.  DOI  PubMed
               37.       Mehnert A, Hartung TJ, Friedrich M, et al. One in two cancer patients is significantly distressed: prevalence and indicators of
                    distress. Psychooncology 2018;27:75-82.  DOI
               38.       Hass HG, Seywald M, Wöckel A, Muco B, Tanriverdi M, Stepien J. Psychological distress in breast cancer patients during
                    oncological inpatient rehabilitation: incidence, triggering factors and correlation with treatment-induced side effects. Arch Gynecol
                    Obstet 2023;307:919-25.  DOI  PubMed
               39.       Coriddi M, Kim LN, Haglich K, et al. The impact of lymphedema on patient-reported outcomes after breast reconstruction: a
                    preliminary propensity score-matched analysis. Ann Surg Oncol 2023;30:3061-71.  DOI  PubMed  PMC
               40.       Fu MR. Women at work with breast cancer-related lymphoedema. J Lymphoedema 2008;3:20-5.  PubMed  PMC
               41.       Moffatt CJ, Franks PJ, Doherty DC, et al. Lymphoedema: an underestimated health problem. QJM 2003;96:731-8.  DOI  PubMed
               42.       Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of
                    working age: a 2-year follow-up study. J Clin Oncol 2009;27:2007-14.  DOI
               43.       Vella F, Filetti V, Cirrincione L, et al. Work ability after breast cancer: study of healthcare personnel operating in a hospital of South
                    Italy. Int J Environ Res Public Health 2022;19:10835.  DOI  PubMed  PMC
               44.       Dean LT, Moss SL, Ransome Y, et al. "It still affects our economic situation": long-term economic burden of breast cancer and
                    lymphedema. Support Care Cancer 2019;27:1697-708.  DOI  PubMed  PMC
               45.       Pereira ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-
                    up. Breast 2017;36:67-73.  DOI  PubMed
               46.       Liu YF, Liu JE, Mak YW, et al. Prevalence and predictors of breast cancer-related arm lymphedema over a 10-year period in
                    postoperative breast cancer patients: a cross-sectional study. Eur J Oncol Nurs 2021;51:101909.  DOI
               47.       Mikami T, Koyama A, Hashimoto K, et al. Pathological changes in the lymphatic system of patients with secondary upper limb
                    lymphoedema. Sci Rep 2019;9:8499.  DOI  PubMed  PMC
               48.       Quartuccio N, Siracusa M, Pappalardo M, Arnone A, Arnone G. Sentinel node identification in melanoma: current clinical impact,
                    new emerging SPECT radiotracers and technological advancements. an update of the last decade. Curr Radiopharm 2020;13:32-41.
                    DOI  PubMed  PMC
               49.       Smoot BJ, Mastick J, Shepherd J, et al. Use of dual-energy X-ray absorptiometry to assess soft tissue composition in breast cancer
                    survivors with and without lymphedema. Lymphat Res Biol 2022;20:391-7.  DOI  PubMed  PMC
               50.       Johnson KC, DeSarno M, Ashikaga T, Dee J, Henry SM. Ultrasound and clinical measures for lymphedema. Lymphat Res Biol
                    2016;14:8-17.  DOI  PubMed
               51.       Canales-Lachén E, Asunsolo Á, Manrique OJ, Blázquez J, Holguín P, Maldonado AA. The use of ultrasound imaging for upper
                    extremity lymphedema after breast cancer: a systematic review. J Reconstr Microsurg 2023;39:102-10.  DOI  PubMed
               52.       Thomis S, Devoogdt N, De Vrieze T, Bechter-Hugl B, Heroes AK, Fourneau I. Relation between early disturbance of lymphatic
                    transport visualized with lymphofluoroscopy and other clinical assessment methods in patients with breast cancer. Clin Breast Cancer
                    2022;22:e37-47.  DOI  PubMed
               53.       Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res
                    Biol 2005;3:208-17.  DOI
               54.       Tierney S, Aslam M, Rennie K, Grace P. Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vasc
                    Endovasc Surg 1996;12:412-7.  DOI  PubMed
               55.       Hayes S, Cornish B, Newman B. Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-
                    up. Breast Cancer Res Treat 2005;89:221-6.  DOI  PubMed
               56.       Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, Thomas BJ. Early diagnosis of lymphedema using multiple
                    frequency bioimpedance. Lymphology 2001;34:2-11.  PubMed
               57.       Vicini F, Shah C, Lyden M, Whitworth P. Bioelectrical impedance for detecting and monitoring patients for the development of
                    upper limb lymphedema in the clinic. Clin Breast Cancer 2012;12:133-7.  DOI  PubMed
               58.       Shah C, Vicini F, Beitsch P, et al. The use of bioimpedance spectroscopy to monitor therapeutic intervention in patients treated for
                    breast cancer related lymphedema. Lymphology 2013;46:184-92.  PubMed
               59.       Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL. Confirmation of the reference impedance ratios used for assessment of
                    breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol 2011;9:47-51.  DOI  PubMed
               60.       Czerniec SA, Ward LC, Lee MJ, Refshauge KM, Beith J, Kilbreath SL. Segmental measurement of breast cancer-related arm
                    lymphoedema using perometry and bioimpedance spectroscopy. Support Care Cancer 2011;19:703-10.  DOI  PubMed
               61.       Hayes S, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema secondary to breast cancer: how choice of measure influences
                    diagnosis, prevalence, and identifiable risk factors. Lymphology 2008;41:18-28.  PubMed
               62.       Pappalardo M, Starnoni M, Franceschini G, Baccarani A, De Santis G. Breast cancer-related lymphedema: recent updates on
   37   38   39   40   41   42   43   44   45   46   47